Diagnostic Ventures


Diagnostic Ventures is focused on advancing rapid diagnostics technology to improve patient outcomes, especially in the detection of sepsis. Their mission is to build diagnostic technology solutions for time-critical conditions, leveraging innovative approaches developed at Brigham Young University with significant funding and patents. They aim to provide fast, accurate, and affordable diagnostic tests, including a rapid sepsis test that delivers results in 1 hour, significantly faster than current methods. The company collaborates with leading researchers and healthcare professionals to tackle complex health issues and improve diagnostic capabilities.

Industries

biotechnology
health-care
manufacturing
medical-device

Nr. of Employees

small (1-50)

Diagnostic Ventures

Salt Lake City, Utah, United States, North America


Products

Rapid sepsis diagnostic (platform combining centrifugal sample preparation and multiplex qPCR)

A diagnostic platform under development that combines centrifugal sample preparation (single-use disk) with multiplex qPCR to identify sepsis pathogens from whole blood without a culture step; the site states initial detection of five pathogenic targets with R&D to expand coverage. The product is stated to be under development and not FDA approved.


Services

Chemical research

Laboratory chemical research activities supporting assay and diagnostic development.

Advanced microscopy

Microscopy services used for sample characterization and research support.

Anatomical pathology

Pathology services and related testing used in clinical laboratory contexts.

Single-use centrifugal disk supply

Provision and development of single-use centrifugal disks for blood sample processing in the diagnostic workflow.

Multiplex molecular assay services

Development and application of multiplex qPCR assays for pathogen and resistance gene detection in blood samples.

Routine clinical laboratory testing

Standard clinical tests offered or referenced such as complete blood count, electrolyte panels, bilirubin, lipid profiles, glucose tolerance testing and urinalysis.

Expertise Areas

  • Rapid molecular diagnostics
  • Sample preparation using centrifugal microfluidics
  • Multiplex qPCR assay development
  • Pathogen detection from whole blood
  • Show More (5)

Key Technologies

  • Multiplex quantitative PCR (qPCR)
  • Centrifugal microfluidic sample preparation (spinning disk)
  • Single-use diagnostic consumables
  • Molecular pathogen detection
  • Show More (4)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.